
Akeso Secures U.S. Orphan Drug Status for Cancer Therapy Ligufalimab
Sep 16, 2025 06:14 am UTC| Business Health
Chinese biotech company Akeso Inc. (HK:9926) announced that its experimental cancer drug ligufalimab (AK117) has received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for the treatment of...

FDA Clears Apple Watch Hypertension Detection Feature for Global Rollout
Sep 13, 2025 06:02 am UTC| Health Business Technology Governance
Apple has received clearance from the U.S. Food and Drug Administration (FDA) to launch a hypertension detection feature on select Apple Watch models. The health regulator confirmed the approval late Friday, giving Apple...

Trump Administration Pledges $250M in Health Aid to Philippines
Sep 12, 2025 03:03 am UTC| Politics Health
The Trump administration has announced an additional $250 million in aid to the Philippines, aimed at combating tuberculosis, improving maternal health, and addressing emerging disease threats. U.S. Secretary of State...

Robert F. Kennedy Jr. Assures Vaccines Will Remain Available Under Trump Administration
Sep 10, 2025 02:32 am UTC| Politics Governance Health
U.S. Health Secretary Robert F. Kennedy Jr. emphasized during an interview on Fox News Special Report with Bret Baier that the Trump administration has no plans to restrict access to vaccines. Kennedy clarified that...

Neuralink Expands Brain Implant Trials with 12 Global Patients
Sep 10, 2025 01:57 am UTC| Technology Business Science Health
Elon Musks brain-computer interface company, Neuralink, announced that 12 people worldwide have now received its brain implants. This is up from seven patients reported in June, when the companys partner, Barrow...

Novartis to Acquire Tourmaline Bio in $1.4 Billion Deal to Boost Heart Disease Portfolio
Sep 09, 2025 06:23 am UTC| Business Health
Novartis announced it will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at approximately $1.4 billion on a fully diluted basis. The Swiss pharmaceutical giant confirmed...

FDA Fast-Tracks Nicotine Pouch Reviews for Major Tobacco Firms
Sep 08, 2025 04:43 am UTC| Business Governance Health
The U.S. Food and Drug Administration (FDA) is set to fast-track reviews of nicotine pouches from Philip Morris International (PMI), Altria, Reynolds American (part of British American Tobacco), and Turning Point Brands in...